FLUOTHANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluothane, and when can generic versions of Fluothane launch?
Fluothane is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in FLUOTHANE is halothane. There are four drug master file entries for this compound. Additional details are available on the halothane profile page.
Summary for FLUOTHANE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 1 |
Patent Applications: | 3,141 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLUOTHANE at DailyMed |
Recent Clinical Trials for FLUOTHANE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Nanjing Medical University | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for FLUOTHANE
US Patents and Regulatory Information for FLUOTHANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | FLUOTHANE | halothane | LIQUID;INHALATION | 011338-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |